Skip to main content

Our Team

Leadership at Amavita Research

Globally recognized cardiovascular investigators leading clinical trials in Miami.

Portrait of Dr. William W. O'Neill
FACCTAVR PioneerStructural Heart

Dr. William W. O'Neill, MD, FACC

Chief Medical Officer & Senior Principal Investigator

Internationally renowned interventional cardiologist and pioneer in structural heart disease. Medical Director, Center for Structural Heart Disease, Henry Ford Hospital · Chief Medical Advisor, CardioElite™. Performed the first TAVR in the United States and served as National Principal Investigator for the Edwards PARTNER, Protect II, and Protect IV trials.

Portrait of Dr. Pedro Martinez-Clark
FACCHarvard-TrainedTrans-Caval TAVR

Dr. Pedro Martinez-Clark, MD, FACC

Co-Investigator · Cardiology Lead · Founder & CEO, amavita Heart and Vascular Health®

Harvard-trained interventional cardiologist with 15+ years of experience and 25+ clinical research trials, including pivotal work helping develop the Trans-Caval TAVR approach. Founder and CEO of amavita Heart and Vascular Health®.

View full profile →
Portrait of Nereisy Alonso
BD Director

Nereisy Alonso, Sr CRC

Business Development Director

Senior Clinical Research Coordinator and Business Development lead. Single point of contact for sponsors evaluating Amavita Research.